XML 24 R13.htm IDEA: XBRL DOCUMENT
v3.25.3

Fair Value Measurements | 9 Months Ended
--- | ---
Nov. 01, 2025
Fair Value Disclosures [Abstract] |
Fair Value Measurements | Fair Value Measurements The Company measures certain financial assets and liabilities at fair value on a recurring basis. The Company categorizes financial assets and liabilities recorded at fair value based upon a three-level hierarchy that considers the related valuation techniques. There were no material purchases, sales, issuances, or settlements related to recurring level 3 measurements for the 13 and 39 weeks ended November 1, 2025 or November 2, 2024. Financial assets and liabilities measured at fair value on a recurring basis and cash equivalents are as follows:
|  |  | Fair Value Measurements at Reporting Date Using
($ in millions) | November 1, 2025 |  | Quoted Prices in Active Markets for Identical Assets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3)
Assets: |  |  |  |  |  |  |
Cash equivalents | $ | 242 |  |  | $ | 229 |  |  | $ | 13 |  |  | $ | — |
Short-term investments | 255 |  |  | 136 |  |  | 119 |  |  | — |
Derivative financial instruments | 20 |  |  | — |  |  | 20 |  |  | — |
Deferred compensation plan assets | 45 |  |  | 45 |  |  | — |  |  | — |
Other assets | 3 |  |  | — |  |  | — |  |  | 3 |
Total | $ | 565 |  |  | $ | 410 |  |  | $ | 152 |  |  | $ | 3 |
Liabilities: |  |  |  |  |  |  |
Derivative financial instruments | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
|  |  | Fair Value Measurements at Reporting Date Using
($ in millions) | February 1, 2025 |  | Quoted Prices in Active Markets for Identical Assets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3)
Assets: |  |  |  |  |  |  |
Cash equivalents | $ | 310 |  |  | $ | 302 |  |  | $ | 8 |  |  | $ | — |
Short-term investments | 253 |  |  | 132 |  |  | 121 |  |  | — |
Derivative financial instruments | 33 |  |  | — |  |  | 33 |  |  | — |
Deferred compensation plan assets | 36 |  |  | 36 |  |  | — |  |  | — |
Other assets | 3 |  |  | — |  |  | — |  |  | 3 |
Total | $ | 635 |  |  | $ | 470 |  |  | $ | 162 |  |  | $ | 3 |
Liabilities: |  |  |  |  |  |  |
Derivative financial instruments | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
|  |  | Fair Value Measurements at Reporting Date Using
($ in millions) | November 2, 2024 |  | Quoted Prices in Active Markets for Identical Assets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3)
Assets: |  |  |  |  |  |  |
Cash equivalents | $ | 8 |  |  | $ | 1 |  |  | $ | 7 |  |  | $ | — |
Short-term investments | 250 |  |  | 130 |  |  | 120 |  |  | — |
Derivative financial instruments | 19 |  |  | — |  |  | 19 |  |  | — |
Deferred compensation plan assets | 38 |  |  | 38 |  |  | — |  |  | — |
Other assets | 4 |  |  | — |  |  | — |  |  | 4 |
Total | $ | 319 |  |  | $ | 169 |  |  | $ | 146 |  |  | $ | 4 |
Liabilities: |  |  |  |  |  |  |
Derivative financial instruments | $ | 1 |  |  | $ | — |  |  | $ | 1 |  |  | $ | — |
We have highly liquid fixed and variable income investments classified as cash equivalents and short-term investments. All highly liquid investments with original maturities of three months or less at the time of purchase are classified as cash and cash equivalents on the Condensed Consolidated Balance Sheets. Our cash equivalents are comprised of money market funds and time deposits recorded at amortized cost, which approximates fair value, as well as debt securities recorded at fair value using market prices for identical or similar assets. We also have highly liquid investments with original maturities of greater than three months and less than two years that are classified as short-term investments on the Condensed Consolidated Balance Sheets. These debt securities are also recorded at fair value using market prices for identical or similar assets. There were no material realized or unrealized gains or losses or impairment charges related to short-term investments during the 13 and 39 weeks ended November 1, 2025 or November 2, 2024. Derivative financial instruments primarily include foreign exchange forward contracts. See Note 6 of Notes to Condensed Consolidated Financial Statements for information regarding currencies hedged against the U.S. dollar. We maintain the Gap Inc. Deferred Compensation Plan (“DCP”), which allows eligible employees to defer base compensation and bonus up to a maximum percentage, and non-employee directors to defer receipt of a portion of their Board fees. Plan investments are directed by participants and are recorded at market value and designated for the DCP. The fair value of the Company’s DCP assets is determined based on quoted market prices, and the assets are recorded in other long-term assets on the Condensed Consolidated Balance Sheets. Nonfinancial Assets We review the carrying amount of long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The fair value of the long-lived assets is determined using level 3 inputs and based on discounted future cash flows of the asset or asset group using a discount rate commensurate with the risk. The asset group is defined as the lowest level for which identifiable cash flows are available and largely independent of the cash flows of other groups of assets, which for our retail stores is at the store level. There were no material impairment charges recorded for long-lived assets during the 13 and 39 weeks ended November 1, 2025 or November 2, 2024. We review the carrying amount of goodwill and other indefinite-lived intangible assets for impairment annually and whenever events or changes in circumstances indicate that it is more likely than not that the carrying amount may not be recoverable. There were no impairment charges recorded for goodwill or other indefinite-lived intangible assets during the 13 and 39 weeks ended November 1, 2025 or November 2, 2024.

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/820/tableOfContent + Details
Name: | us-gaap_FairValueMeasurementInputsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration